Lingmin Zhang

机构：State Key Laboratory of Respiratory Disease, Guangzhou Medical University · ORCID：0000-0003-2284-1452

发表论文 92 篇 · 总被引 1772 次 · h-index 25

代表论文

• A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage (2023 · Nano Today · 被引 110)
• Oral carbon dot nanozymes with red fluorescence and superoxide dismutase-like activity for colitis bioimaging and inflammation management (2024 · Chemical Engineering Journal · 被引 63)
• Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy (2024 · Journal of Nanobiotechnology · 被引 48)
• Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis (2023 · ACS Applied Materials & Interfaces · 被引 40)
• Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9 (2022 · Acta Pharmacologica Sinica · 被引 30)
• Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization (2023 · MedComm · 被引 28)